AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2012
Jan 4, 2012
34301_dirs_2012-01-04_0a30bdcd-96b6-4219-96b3-3e3efd529e34.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-01-01
Reporting Person: RICKEY DAVID (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-01-01 | Restricted Stock Award (Common Stock) | A | 10000 | — | Acquired | 10000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-01-01 | Non-Qualified Stock Opiton | $2.2 | A | 15000 | Acquired | 2022-01-01 | Common Stock (15000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 88559 | Indirect |
| Common Stock | 34909 | Indirect |
| Common Stock | 146101 | Indirect |
Footnotes
F1: These securities are owned by the Dave Rickey and Daughters Foundation.
F2: These securities are owned by David M Rickey, Trustee FBO The Rickey Annunity Trust.
F3: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust
F4: The Restricted Stock Award vests in full on December 31, 2012, subject to the terms of the Company's 2004 Equity Incentive Plan.
F5: The stock options vest 1/24th each month from date of grant, subject to the terms of the 2004 Equity Incentive Plan.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26